""	"Name"	"Genes (tot)"	"Stat (dist.dir.up)"	"p (dist.dir.up)"	"p adj (dist.dir.up)"	"Stat (dist.dir.dn)"	"p (dist.dir.dn)"	"p adj (dist.dir.dn)"	"Stat (non-dir.)"	"p (non-dir.)"	"p adj (non-dir.)"	"Genes (up)"	"Stat (mix.dir.up)"	"p (mix.dir.up)"	"p adj (mix.dir.up)"	"Genes (down)"	"Stat (mix.dir.dn)"	"p (mix.dir.dn)"	"p adj (mix.dir.dn)"
"1"	"ABC transporters"	11	1.579	0.23912	1	-1.579	0.76088	0.93576	-10.184	0.80798	0.99996	8	-9.6022	0.81436	0.97645	3	-3.8206	0.50475	0.99999
"2"	"AGE-RAGE signaling pathway in diabetic complications"	39	-2.7559	0.9951	1	2.7559	0.0049044	0.036499	-14.736	0.71437	0.99996	11	-8.5714	0.7268	0.96722	28	-12.018	0.57102	0.99999
"3"	"AMPK signaling pathway"	56	-0.066775	0.82169	1	0.066775	0.17831	0.36017	-13.116	0.35981	0.94604	27	-8.0878	0.3839	0.86395	29	-10.422	0.42099	0.99999
"4"	"Acute myeloid leukemia"	28	-1.0781	0.88386	1	1.0781	0.11614	0.2731	-16.668	0.9236	0.99996	9	-6.1577	0.57957	0.93693	19	-15.996	0.95084	0.99999
"5"	"Adherens junction"	32	-0.32913	0.79714	1	0.32913	0.20286	0.39008	-10.576	0.44302	0.98758	17	-9.65	0.6749	0.96722	15	-5.1746	0.22907	0.87028
"6"	"Adipocytokine signaling pathway"	31	1.2564	0.46437	1	-1.2564	0.53563	0.7384	-15.421	0.8516	0.99996	16	-6.6193	0.43026	0.86395	15	-15.332	0.96211	0.99999
"7"	"Adrenergic signaling in cardiomyocytes"	57	-4.6561	0.9999	1	4.6561	0.00010069	0.0029126	-6.61	0.026921	0.2737	21	-6.3739	0.34753	0.8629	36	-3.4492	0.015917	0.46766
"8"	"African trypanosomiasis"	14	0.74323	0.4776	1	-0.74323	0.5224	0.73089	-6.6158	0.44654	0.98758	9	-4.1918	0.40775	0.86395	5	-5.4464	0.59402	0.99999
"9"	"Alanine, aspartate and glutamate metabolism"	16	3.2819	0.045949	0.40042	-3.2819	0.95405	1	-1.2053	0.065815	0.39251	10	0.20202	0.095393	0.6439	6	-2.2291	0.24153	0.87028
"10"	"Alcoholism"	29	-0.68241	0.85185	1	0.68241	0.14815	0.31821	-8.1819	0.30318	0.86314	13	-3.3256	0.25122	0.8468	16	-8.0176	0.44099	0.99999
"11"	"Aldosterone synthesis and secretion"	24	-2.244	0.97716	1	2.244	0.022844	0.093491	-6.9478	0.28171	0.82721	11	-9.1805	0.77136	0.96722	13	-0.99531	0.059956	0.61798
"12"	"Aldosterone-regulated sodium reabsorption"	16	0.034701	0.66149	1	-0.034701	0.33851	0.55211	-9.0869	0.63453	0.99996	5	1.3522	0.11954	0.72457	11	-11.871	0.86987	0.99999
"13"	"Allograft rejection"	4	-0.53278	0.72027	1	0.53278	0.27973	0.48702	-8.5357	0.85898	0.99996	1	-8.2095	0.93377	0.99293	3	-5.1164	0.62208	0.99999
"14"	"Alzheimer disease"	113	24.919	0	0	-24.919	1	1	20.101	0	0	90	23.44	0	0	23	-1.8128	0.025258	0.60672
"15"	"Amino sugar and nucleotide sugar metabolism"	27	-0.78431	0.85966	1	0.78431	0.14034	0.31043	-2.4945	0.036651	0.31939	13	-2.4199	0.19442	0.791	14	-1.1322	0.048936	0.60762
"16"	"Aminoacyl-tRNA biosynthesis"	21	8.7163	2.1832e-07	4.7562e-06	-8.7163	1	1	1.467	0.010577	0.13442	19	1.2464	0.020523	0.22575	2	0.91204	0.17704	0.85095
"17"	"Amoebiasis"	42	-2.6196	0.99097	1	2.6196	0.0090252	0.055054	-13.068	0.53271	0.99996	17	-11.472	0.8082	0.97645	25	-7.4777	0.22241	0.87028
"18"	"Amphetamine addiction"	20	-4.7877	0.9998	1	4.7877	0.00019595	0.0039842	-0.23046	0.02387	0.26002	5	-2.3907	0.36566	0.8629	15	1.1141	0.010709	0.35458
"19"	"Amyotrophic lateral sclerosis (ALS)"	21	-1.0919	0.88526	1	1.0919	0.11474	0.2731	-2.0644	0.066176	0.39251	9	-0.91197	0.16912	0.75461	12	-1.9412	0.089633	0.76298
"20"	"Antigen processing and presentation"	24	0.8113	0.50684	1	-0.8113	0.49316	0.7055	-6.9708	0.28353	0.82721	14	-3.7178	0.26434	0.86274	10	-6.4001	0.46804	0.99999
"21"	"Apelin signaling pathway"	54	0.87571	0.61282	1	-0.87571	0.38718	0.61056	-14.067	0.46013	0.98832	25	-2.9998	0.080831	0.61176	29	-16.41	0.89319	0.99999
"22"	"Apoptosis"	49	0.58411	0.68493	1	-0.58411	0.31507	0.52325	-18.086	0.86123	0.99996	20	-4.9757	0.23014	0.82447	29	-19.377	0.97493	0.99999
"23"	"Arachidonic acid metabolism"	15	0.63015	0.51668	1	-0.63015	0.48332	0.70196	-6.1074	0.37791	0.96037	7	-6.169	0.61294	0.95161	8	-2.5924	0.20452	0.87028
"24"	"Arginine and proline metabolism"	27	5.2633	0.0020525	0.022357	-5.2633	0.99795	1	-0.18455	0.0098719	0.13091	19	1.169	0.021407	0.22707	8	-2.1407	0.17537	0.85095
"25"	"Arginine biosynthesis"	11	5.0889	0.0011103	0.013545	-5.0889	0.99889	1	-0.59794	0.085387	0.4569	9	-0.25013	0.13484	0.75461	2	-0.87168	0.31086	0.94194
"26"	"Arrhythmogenic right ventricular cardiomyopathy (ARVC)"	36	-4.9984	0.99996	1	4.9984	4.0153e-05	0.0017495	-5.967	0.099435	0.50546	12	-5.6427	0.43407	0.86395	24	-3.3181	0.056436	0.61798
"27"	"Ascorbate and aldarate metabolism"	6	2.1383	0.14221	0.96387	-2.1383	0.85779	1	0.51921	0.11066	0.51925	5	-0.70311	0.23596	0.82447	1	2.844	0.11504	0.80884
"28"	"Asthma"	2	-0.16807	0.63137	1	0.16807	0.36863	0.59175	-6.4313	0.78321	0.99996	0				2	-6.4313	0.80431	0.99999
"29"	"Autoimmune thyroid disease"	4	-0.53278	0.72027	1	0.53278	0.27973	0.48702	-8.5357	0.85898	0.99996	1	-8.2095	0.93377	0.99293	3	-5.1164	0.62208	0.99999
"30"	"Autophagy"	56	-0.86829	0.92512	1	0.86829	0.074878	0.20762	-20.401	0.90482	0.99996	23	-10.258	0.64461	0.95161	33	-18.011	0.91913	0.99999
"31"	"Axon guidance"	55	-2.5947	0.99236	1	2.5947	0.0076399	0.047555	-17.538	0.75166	0.99996	21	-11.708	0.78037	0.96722	34	-13.105	0.58012	0.99999
"32"	"B cell receptor signaling pathway"	27	-3.8557	0.99898	1	3.8557	0.0010203	0.011114	-15.46	0.89275	0.99996	7	-11.247	0.91825	0.99293	20	-11.309	0.66727	0.99999
"33"	"Bacterial invasion of epithelial cells"	42	0.82748	0.55515	1	-0.82748	0.44485	0.6651	-13.091	0.53488	0.99996	26	-9.3456	0.52519	0.93693	16	-9.2971	0.56142	0.99999
"34"	"Basal cell carcinoma"	4	0.54327	0.45243	1	-0.54327	0.54757	0.74226	-12.019	0.96936	0.99996	1	0.59105	0.32108	0.8629	3	-14.219	0.99206	0.99999
"35"	"Basal transcription factors"	4	0.74127	0.40171	1	-0.74127	0.59829	0.79338	-8.4053	0.85221	0.99996	2	-0.27679	0.29399	0.8629	2	-11.61	0.98279	0.99999
"36"	"Base excision repair"	8	-0.41755	0.71737	1	0.41755	0.28263	0.48702	-14.636	0.98519	0.99996	2	-6.0928	0.77425	0.96722	6	-13.383	0.97723	0.99999
"37"	"Bile secretion"	15	0.67349	0.505	1	-0.67349	0.495	0.7055	-7.1341	0.47202	0.99977	8	-4.618	0.43654	0.86395	7	-5.5064	0.49833	0.99999
"38"	"Biosynthesis of unsaturated fatty acids"	11	2.0482	0.15309	0.99345	-2.0482	0.84691	0.99703	-2.7677	0.19416	0.70498	6	1.2113	0.10753	0.6943	5	-5.4321	0.59265	0.99999
"39"	"Bladder cancer"	12	-1.089	0.85823	1	1.089	0.14177	0.31043	-9.6023	0.72982	0.99996	5	-8.3132	0.83551	0.98082	7	-5.5465	0.50223	0.99999
"40"	"Breast cancer"	22	-1.2337	0.9012	1	1.2337	0.098796	0.24699	-15.823	0.94587	0.99996	5	-2.7677	0.39768	0.86395	17	-16.499	0.97487	0.99999
"41"	"Butanoate metabolism"	16	8.1106	7.5039e-07	1.5258e-05	-8.1106	1	1	-0.92885	0.0579	0.3839	14	3.3952	0.012499	0.15468	2	-11.61	0.98279	0.99999
"42"	"C-type lectin receptor signaling pathway"	33	-4.566	0.99973	1	4.566	0.00027046	0.0043415	-14.594	0.78347	0.99996	7	-10.623	0.8957	0.99293	26	-10.93	0.54205	0.99999
"43"	"Calcium signaling pathway"	51	-3.6015	0.99928	1	3.6015	0.00072336	0.0096464	-1.5885	0.0027356	0.043913	21	-3.6911	0.164	0.75461	30	1.0171	0.0010123	0.10055
"44"	"Carbohydrate digestion and absorption"	12	-0.52382	0.75797	1	0.52382	0.24203	0.43423	-5.8528	0.40962	0.98758	5	0.23703	0.17649	0.75461	7	-7.8634	0.71614	0.99999
"45"	"Cardiac muscle contraction"	41	10.821	7.2109e-10	1.8328e-08	-10.821	1	1	8.7999	3.686e-07	1.1242e-05	31	11.509	4.8692e-07	1.4462e-05	10	-2.4455	0.15027	0.85095
"46"	"Cell adhesion molecules (CAMs)"	24	1.4775	0.33913	1	-1.4775	0.66087	0.84449	-21.401	0.99742	0.99996	13	-10.394	0.794	0.97044	11	-20.313	0.99903	0.99999
"47"	"Cell cycle"	32	-2.3825	0.98238	1	2.3825	0.017616	0.082661	-23.088	0.99666	0.99996	9	-14.017	0.97359	0.99293	23	-18.465	0.97899	0.99999
"48"	"Cellular senescence"	49	-0.79362	0.91229	1	0.79362	0.087711	0.23034	-9.833	0.20141	0.71431	23	-6.5028	0.31147	0.8629	26	-7.3827	0.23021	0.87028
"49"	"Central carbon metabolism in cancer"	33	0.61989	0.59625	1	-0.61989	0.40375	0.6251	-7.3218	0.17911	0.6915	15	-2.7478	0.17096	0.75461	18	-7.4053	0.34451	0.96714
"50"	"Chagas disease (American trypanosomiasis)"	33	-2.2274	0.97775	1	2.2274	0.022251	0.092965	-17.623	0.93232	0.99996	10	-9.0922	0.78029	0.96722	23	-15.115	0.89079	0.99999
"51"	"Chemical carcinogenesis"	21	3.1463	0.066713	0.52173	-3.1463	0.93329	1	-3.3955	0.11444	0.52097	9	4.8275	0.013035	0.15486	12	-8.6726	0.6383	0.99999
"52"	"Chemokine signaling pathway"	50	-0.90679	0.90681	1	0.90679	0.093189	0.23685	-22.557	0.98179	0.99996	20	-9.9164	0.64127	0.95161	30	-21.025	0.98934	0.99999
"53"	"Cholesterol metabolism"	21	1.5658	0.31103	1	-1.5658	0.68897	0.86833	-5.3315	0.22229	0.74363	14	-4.0021	0.28583	0.8629	7	-3.5747	0.31706	0.94194
"54"	"Choline metabolism in cancer"	35	-1.6096	0.95898	1	1.6096	0.041024	0.1472	-14.909	0.78162	0.99996	14	-10.534	0.81968	0.97769	21	-10.647	0.59534	0.99999
"55"	"Cholinergic synapse"	30	-1.6266	0.95448	1	1.6266	0.045518	0.15599	-10.383	0.43588	0.98758	10	-1.1608	0.15792	0.75461	20	-11.896	0.71759	0.99999
"56"	"Chronic myeloid leukemia"	30	-2.6237	0.99009	1	2.6237	0.0099117	0.057923	-18.487	0.95438	0.99996	6	-7.985	0.77152	0.96722	24	-16.677	0.92646	0.99999
"57"	"Circadian entrainment"	29	-2.2381	0.97807	1	2.2381	0.021932	0.092908	-6.7137	0.19883	0.71344	9	-0.53241	0.14883	0.75461	20	-7.7273	0.32937	0.96228
"58"	"Circadian rhythm"	9	0.02343	0.63257	1	-0.02343	0.36743	0.59175	-5.102	0.43013	0.98758	6	-3.7756	0.43484	0.86395	3	-3.4974	0.47502	0.99999
"59"	"Citrate cycle (TCA cycle)"	29	17.019	0	0	-17.019	1	1	12.979	6.4809e-08	2.1963e-06	27	13.715	2.2172e-07	7.3169e-06	2	-0.96882	0.31925	0.94194
"60"	"Cocaine addiction"	10	0.60409	0.51153	1	-0.60409	0.48847	0.70275	-5.2812	0.44361	0.98758	4	0.23368	0.19917	0.79117	6	-7.0088	0.67582	0.99999
"61"	"Collecting duct acid secretion"	11	-0.59478	0.77225	1	0.59478	0.22775	0.41901	-3.0226	0.21096	0.72643	5	-4.1746	0.52157	0.93693	6	-0.28172	0.12041	0.80884
"62"	"Colorectal cancer"	31	-0.30433	0.80689	1	0.30433	0.19311	0.38042	-14.855	0.81926	0.99996	10	-2.7402	0.25805	0.85158	21	-16.158	0.94291	0.99999
"63"	"Complement and coagulation cascades"	38	1.0214	0.52267	1	-1.0214	0.47733	0.69962	-16.905	0.8703	0.99996	28	-11.094	0.63729	0.95161	10	-14.39	0.9678	0.99999
"64"	"Cortisol synthesis and secretion"	9	-0.99405	0.83763	1	0.99405	0.16237	0.33488	-3.2568	0.27697	0.82721	4	-3.1372	0.46966	0.88846	5	-1.5634	0.23547	0.87028
"65"	"Cushing syndrome"	33	-1.2931	0.92363	1	1.2931	0.076366	0.20983	-11.84	0.55535	0.99996	13	-8.8676	0.69092	0.96722	20	-8.0598	0.35924	0.98214
"66"	"Cysteine and methionine metabolism"	29	4.0699	0.027325	0.26885	-4.0699	0.97267	1	1.948	0.0025879	0.043851	18	6.1392	0.0010807	0.021398	11	-4.6904	0.29015	0.91982
"67"	"Cytokine-cytokine receptor interaction"	3	-0.18272	0.60764	1	0.18272	0.39236	0.61056	-9.8719	0.92245	0.99996	2	-11.61	0.97621	0.99293	1	-0.67964	0.35862	0.98214
"68"	"Cytosolic DNA-sensing pathway"	11	0.52638	0.49826	1	-0.52638	0.50174	0.71177	-20.421	0.99945	0.99996	3	-5.5318	0.71358	0.96722	8	-20.558	0.99972	0.99999
"69"	"D-Glutamine and D-glutamate metabolism"	3	1.7814	0.16391	1	-1.7814	0.83609	0.99225	-3.4054	0.49602	0.99996	2	-3.5816	0.57687	0.93693	1	-0.83323	0.37236	0.99967
"70"	"DNA replication"	9	-0.80655	0.80667	1	0.80655	0.19333	0.38042	-8.8917	0.7511	0.99996	1	2.7263	0.17298	0.75461	8	-10.395	0.849	0.99999
"71"	"Dilated cardiomyopathy (DCM)"	45	-4.378	0.99986	1	4.378	0.00014409	0.0036622	-2.8754	0.0090727	0.12578	18	-2.9263	0.14239	0.75461	27	-1.3228	0.0080035	0.29813
"72"	"Dopaminergic synapse"	46	-4.4671	0.99982	1	4.4671	0.00017832	0.0038848	-8.1404	0.10931	0.51925	14	-5.4969	0.41022	0.86395	32	-6.1242	0.086681	0.76298
"73"	"Drug metabolism"	38	1.9737	0.2891	1	-1.9737	0.7109	0.88997	-10.218	0.32204	0.88488	18	-4.4103	0.22885	0.82447	20	-9.9003	0.53534	0.99999
"74"	"ECM-receptor interaction"	38	-1.3807	0.94551	1	1.3807	0.05449	0.16959	-11.315	0.42033	0.98758	16	-8.3308	0.5775	0.93693	22	-7.7669	0.29708	0.92219
"75"	"Endocrine and other factor-regulated calcium reabsorption"	21	-0.40855	0.77814	1	0.40855	0.22186	0.41655	-10.676	0.67246	0.99996	12	-12.065	0.89874	0.99293	9	-2.376	0.16294	0.85095
"76"	"Endocytosis"	125	-0.59267	0.94823	1	0.59267	0.051768	0.1662	-23.033	0.59751	0.99996	63	-15.551	0.59256	0.9513	62	-17.03	0.53587	0.99999
"77"	"Endometrial cancer"	20	-1.0185	0.87359	1	1.0185	0.12641	0.28772	-11.894	0.76582	0.99996	5	0.43548	0.16527	0.75461	15	-13.985	0.92532	0.99999
"78"	"Epithelial cell signaling in Helicobacter pylori infection"	30	-1.9194	0.9698	1	1.9194	0.030204	0.11373	-16.029	0.87024	0.99996	14	-14.712	0.9686	0.99293	16	-8.1865	0.45682	0.99999
"79"	"Epstein-Barr virus infection"	74	-3.8775	0.99973	1	3.8775	0.00026809	0.0043415	-27.819	0.99385	0.99996	18	-12.326	0.84171	0.98421	56	-24.991	0.98607	0.99999
"80"	"ErbB signaling pathway"	39	-3.07	0.99735	1	3.07	0.0026501	0.023094	-15.691	0.78153	0.99996	8	-4.7343	0.44624	0.86395	31	-15.194	0.79927	0.99999
"81"	"Estrogen signaling pathway"	34	-1.676	0.96614	1	1.676	0.03386	0.12594	-8.8617	0.28749	0.82721	11	-3.5905	0.29362	0.8629	23	-8.2913	0.34322	0.96714
"82"	"Ether lipid metabolism"	10	-1.8689	0.94599	1	1.8689	0.05401	0.16959	-11.953	0.92048	0.99996	4	-12.563	0.9809	0.99429	6	-5.1745	0.50473	0.99999
"83"	"Fanconi anemia pathway"	5	-1.9534	0.933	1	1.9534	0.066995	0.19307	-6.018	0.65153	0.99996	0				5	-6.018	0.64768	0.99999
"84"	"Fat digestion and absorption"	9	1.6912	0.23565	1	-1.6912	0.76435	0.93625	-3.9892	0.33475	0.90352	7	-2.197	0.28149	0.8629	2	-4.3521	0.63759	0.99999
"85"	"Fatty acid biosynthesis"	7	2.4669	0.096252	0.71602	-2.4669	0.90375	1	0.24737	0.11358	0.52097	4	0.056541	0.21063	0.79188	3	0.31258	0.17312	0.85095
"86"	"Fatty acid degradation"	32	10.641	1.1437e-09	2.6834e-08	-10.641	1	1	2.2084	0.0011018	0.019767	26	3.7861	0.0023495	0.041048	6	-2.7811	0.28512	0.91361
"87"	"Fatty acid elongation"	15	5.8612	0.0002372	0.0038077	-5.8612	0.99976	1	3.5786	0.0049034	0.074776	10	8.2239	0.0009522	0.0202	5	-5.4321	0.59265	0.99999
"88"	"Fc epsilon RI signaling pathway"	27	-2.4381	0.98456	1	2.4381	0.015439	0.076114	-13.554	0.78686	0.99996	8	-9.6197	0.81535	0.97645	19	-9.915	0.57424	0.99999
"89"	"Fc gamma R-mediated phagocytosis"	41	-0.4658	0.83358	1	0.4658	0.16642	0.34066	-11.893	0.44684	0.98758	22	-10.486	0.68698	0.96722	19	-6.187	0.2384	0.87028
"90"	"Ferroptosis"	21	0.9223	0.46707	1	-0.9223	0.53293	0.7384	-4.5795	0.17492	0.69032	11	-3.8555	0.31495	0.8629	10	-2.5927	0.15872	0.85095
"91"	"Fluid shear stress and atherosclerosis"	58	-0.31283	0.85649	1	0.31283	0.14351	0.31043	-20.412	0.89713	0.99996	24	-6.6338	0.31966	0.8629	34	-21.086	0.9846	0.99999
"92"	"Focal adhesion"	101	-2.058	0.99497	1	2.058	0.0050317	0.036499	-17.788	0.33245	0.90352	45	-10.58	0.37636	0.86395	56	-14.404	0.36496	0.9887
"93"	"Folate biosynthesis"	11	0.18335	0.58913	1	-0.18335	0.41087	0.62973	0.71858	0.046734	0.33938	6	-1.1253	0.23095	0.82447	5	2.2986	0.047004	0.60762
"94"	"FoxO signaling pathway"	42	-2.0886	0.9784	1	2.0886	0.021603	0.092803	-13.826	0.60135	0.99996	13	-3.8829	0.2901	0.8629	29	-14.039	0.74928	0.99999
"95"	"Fructose and mannose metabolism"	21	-2.7152	0.98735	1	2.7152	0.012652	0.065403	-1.193	0.044342	0.33938	7	-1.3598	0.22338	0.82447	14	-0.49963	0.035241	0.60762
"96"	"GABAergic synapse"	19	-1.3765	0.91576	1	1.3765	0.084242	0.22342	-5.3259	0.24569	0.78059	9	-3.6506	0.36209	0.8629	10	-3.878	0.24531	0.87028
"97"	"Galactose metabolism"	15	-2.7097	0.98927	1	2.7097	0.010728	0.058427	-0.86951	0.061855	0.38502	7	-2.7978	0.32725	0.8629	8	1.4265	0.037337	0.60762
"98"	"Gap junction"	28	-1.38	0.91673	1	1.38	0.08327	0.22278	-8.86	0.37442	0.96037	11	-4.3546	0.3568	0.8629	17	-7.8679	0.43008	0.99999
"99"	"Gastric acid secretion"	23	-2.3614	0.98053	1	2.3614	0.019472	0.087339	-2.3781	0.060023	0.38502	8	-2.0338	0.24005	0.829	15	-1.4594	0.048187	0.60762
"100"	"Gastric cancer"	29	-0.90619	0.88181	1	0.90619	0.11819	0.2731	-19.192	0.97521	0.99996	8	-4.3688	0.41588	0.86395	21	-19.857	0.99339	0.99999
"101"	"Glioma"	25	-2.6812	0.98974	1	2.6812	0.010255	0.057923	-11.946	0.69553	0.99996	7	-8.5144	0.78757	0.96722	18	-8.7693	0.4705	0.99999
"102"	"Glucagon signaling pathway"	49	-2.2721	0.98906	1	2.2721	0.010945	0.058563	-9.0133	0.15209	0.67227	20	-6.2267	0.32283	0.8629	29	-6.5451	0.12844	0.83087
"103"	"Glutamatergic synapse"	27	-2.9041	0.99311	1	2.9041	0.0068901	0.045528	-6.1043	0.1719	0.69032	10	-6.9457	0.61504	0.95161	17	-2.3658	0.062213	0.61798
"104"	"Glutathione metabolism"	34	3.901	0.033686	0.30218	-3.901	0.96631	1	-4.865	0.066919	0.39251	17	4.7063	0.0022662	0.041048	17	-11.586	0.77132	0.99999
"105"	"Glycerolipid metabolism"	20	1.8782	0.2412	1	-1.8782	0.7588	0.93576	-2.3941	0.069715	0.40119	11	-0.32245	0.097702	0.64483	9	-3.2124	0.21618	0.87028
"106"	"Glycerophospholipid metabolism"	29	-0.58811	0.83782	1	0.58811	0.16218	0.33488	-16.223	0.90237	0.99996	12	-12.475	0.91407	0.99293	17	-10.708	0.7006	0.99999
"107"	"Glycine, serine and threonine metabolism"	17	3.3476	0.056184	0.45095	-3.3476	0.94382	1	-2.294	0.1053	0.50979	9	2.244	0.049001	0.41581	8	-5.7242	0.46815	0.99999
"108"	"Glycolysis / Gluconeogenesis"	47	-1.2275	0.93707	1	1.2275	0.06293	0.18817	3.7914	3.6178e-05	0.0008488	18	4.6866	0.0030066	0.04961	29	1.1344	0.0014198	0.10577
"109"	"Glycosaminoglycan degradation"	5	3.4133	0.029864	0.28464	-3.4133	0.97014	1	-4.2864	0.49354	0.99996	5	-4.2864	0.53149	0.93693	0			
"110"	"Glycosphingolipid biosynthesis"	2	3.1834	0.033134	0.30218	-3.1834	0.96687	1	2.7673	0.10307	0.50878	2	2.7673	0.11134	0.69748	0			
"111"	"Glycosylphosphatidylinositol (GPI)-anchor biosynthesis"	4	0.19478	0.54308	1	-0.19478	0.45692	0.67324	-7.9256	0.82546	0.99996	2	-5.406	0.72576	0.96722	2	-5.8025	0.75939	0.99999
"112"	"Glyoxylate and dicarboxylate metabolism"	23	10.425	1.3208e-10	3.6621e-09	-10.425	1	1	6.2794	0.00017599	0.0033548	18	9.163	9.4465e-05	0.002338	5	-3.9179	0.44451	0.99999
"113"	"GnRH signaling pathway"	33	-4.6186	0.99976	1	4.6186	0.00023947	0.0042963	-8.0442	0.22675	0.74363	7	-6.1963	0.61521	0.95161	26	-5.8476	0.13494	0.83773
"114"	"Graft-versus-host disease"	4	-0.53278	0.72027	1	0.53278	0.27973	0.48702	-8.5357	0.85898	0.99996	1	-8.2095	0.93377	0.99293	3	-5.1164	0.62208	0.99999
"115"	"HIF-1 signaling pathway"	51	-2.7973	0.99606	1	2.7973	0.0039363	0.033349	-11.09	0.25541	0.78688	19	-8.6509	0.58005	0.93693	32	-7.3349	0.14057	0.85095
"116"	"Hedgehog signaling pathway"	9	-2.4177	0.97054	1	2.4177	0.029461	0.11232	-9.219	0.77388	0.99996	0				9	-9.219	0.73623	0.99999
"117"	"Hematopoietic cell lineage"	14	2.0979	0.17616	1	-2.0979	0.82384	0.98153	-9.9833	0.74842	0.99996	8	-1.1991	0.18872	0.77846	6	-13.865	0.98284	0.99999
"118"	"Hepatitis B"	53	-2.3946	0.98942	1	2.3946	0.010583	0.058427	-22.154	0.95905	0.99996	13	-9.3053	0.72266	0.96722	40	-20.196	0.95516	0.99999
"119"	"Hepatitis C"	50	-2.467	0.98975	1	2.467	0.010251	0.057923	-20.9	0.95543	0.99996	14	-8.7779	0.69718	0.96722	36	-19.156	0.9348	0.99999
"120"	"Hepatocellular carcinoma"	43	-1.3889	0.95356	1	1.3889	0.046441	0.15738	-16.769	0.83035	0.99996	13	-5.5361	0.41904	0.86395	30	-16.432	0.88088	0.99999
"121"	"Herpes simplex virus 1 infection"	59	-0.28961	0.84173	1	0.28961	0.15827	0.33292	-25.818	0.99497	0.99996	24	-10.26	0.63379	0.95161	35	-25.026	0.99851	0.99999
"122"	"Hippo signaling pathway"	34	-2.8033	0.99485	1	2.8033	0.0051458	0.036499	-15.689	0.85138	0.99996	11	-11.892	0.91421	0.99293	23	-10.852	0.58302	0.99999
"123"	"Histidine metabolism"	10	2.059	0.18417	1	-2.059	0.81583	0.97579	1.7478	0.037963	0.32163	5	3.72	0.044112	0.38533	5	-1.2482	0.2122	0.87028
"124"	"Homologous recombination"	8	-0.81591	0.79664	1	0.81591	0.20336	0.39008	-4.0473	0.38065	0.96037	2	1.06	0.20064	0.79117	6	-5.2855	0.51546	0.99999
"125"	"Human T-cell leukemia virus 1 infection"	61	-1.1235	0.95735	1	1.1235	0.042647	0.14951	-19.283	0.82926	0.99996	22	-9.7421	0.62475	0.95161	39	-16.799	0.81145	0.99999
"126"	"Human cytomegalovirus infection"	77	-1.3271	0.96514	1	1.3271	0.034862	0.12811	-25.341	0.9696	0.99996	34	-13.762	0.76548	0.96722	43	-21.673	0.97185	0.99999
"127"	"Human immunodeficiency virus 1 infection"	80	-2.6959	0.99771	1	2.6959	0.0022892	0.021684	-22.13	0.85562	0.99996	27	-7.5556	0.34043	0.8629	53	-21.796	0.9418	0.99999
"128"	"Human papillomavirus infection"	110	-3.0583	0.99917	1	3.0583	0.00083467	0.010145	-33.358	0.99905	0.99996	41	-22.578	0.99485	0.99949	69	-24.714	0.95712	0.99999
"129"	"Huntington disease"	113	29.667	0	0	-29.667	1	1	15.976	0	0	97	23.899	0	0	16	-16.387	0.96665	0.99999
"130"	"Hypertrophic cardiomyopathy (HCM)"	48	-2.8828	0.99558	1	2.8828	0.0044162	0.036404	-6.098	0.046239	0.33938	24	-6.0366	0.27354	0.8629	24	-2.5872	0.039931	0.60762
"131"	"IL-17 signaling pathway"	25	-1.4577	0.9372	1	1.4577	0.062796	0.18817	-18.983	0.9842	0.99996	8	-7.2714	0.65589	0.9596	17	-18.032	0.99027	0.99999
"132"	"Inflammatory bowel disease (IBD)"	8	-0.70503	0.77602	1	0.70503	0.22398	0.41655	-10.336	0.87867	0.99996	2	-8.0188	0.88133	0.99293	6	-7.3048	0.70116	0.99999
"133"	"Inflammatory mediator regulation of TRP channels"	29	-3.5389	0.99765	1	3.5389	0.0023476	0.021684	-9.8399	0.44354	0.98758	9	-11.271	0.90823	0.99293	20	-4.2883	0.10011	0.76298
"134"	"Influenza A"	56	-0.833	0.92184	1	0.833	0.078159	0.21284	-16.105	0.62766	0.99996	21	-4.3654	0.20304	0.79117	35	-16.99	0.85358	0.99999
"135"	"Inositol phosphate metabolism"	24	-1.7161	0.95113	1	1.7161	0.048865	0.16026	-14.632	0.8881	0.99996	9	-18.556	0.99835	0.99949	15	-4.1344	0.15873	0.85095
"136"	"Insulin resistance"	53	-0.60504	0.88038	1	0.60504	0.11962	0.27431	-19.579	0.87835	0.99996	21	-6.5458	0.36151	0.8629	32	-19.894	0.96896	0.99999
"137"	"Insulin secretion"	22	-2.6909	0.98525	1	2.6909	0.014752	0.074991	-8.168	0.41815	0.98758	8	-6.1368	0.5641	0.93693	14	-5.6002	0.28406	0.91361
"138"	"Insulin signaling pathway"	77	-1.7639	0.98176	1	1.7639	0.018242	0.0843	-21.875	0.85914	0.99996	30	-13.18	0.76232	0.96722	47	-17.469	0.76916	0.99999
"139"	"Intestinal immune network for IgA production"	2	-0.16807	0.63137	1	0.16807	0.36863	0.59175	-6.4313	0.78321	0.99996	0				2	-6.4313	0.80431	0.99999
"140"	"JAK-STAT signaling pathway"	18	-1.8733	0.94896	1	1.8733	0.05104	0.16561	-13.838	0.8886	0.99996	3	-3.8761	0.57884	0.93693	15	-13.425	0.90369	0.99999
"141"	"Kaposi sarcoma-associated herpesvirus infection"	59	-1.992	0.98098	1	1.992	0.01902	0.086582	-21.801	0.94697	0.99996	21	-10.328	0.68151	0.96722	38	-19.488	0.93605	0.99999
"142"	"Legionellosis"	23	-0.013209	0.70026	1	0.013209	0.29974	0.50509	-2.2573	0.05674	0.3839	10	-0.48016	0.12395	0.73624	13	-2.5814	0.11951	0.80884
"143"	"Leishmaniasis"	15	-1.585	0.93816	1	1.585	0.061845	0.18817	-12.898	0.9	0.99996	3	-6.2838	0.7672	0.96722	12	-11.278	0.84393	0.99999
"144"	"Leukocyte transendothelial migration"	50	1.1084	0.5141	1	-1.1084	0.4859	0.70236	-13.808	0.50895	0.99996	30	-8.1649	0.34614	0.8629	20	-11.832	0.71229	0.99999
"145"	"Linoleic acid metabolism"	3	-0.041171	0.57259	1	0.041171	0.42741	0.64856	-10.393	0.93786	0.99996	2	-11.61	0.97621	0.99293	1	-1.5818	0.44134	0.99999
"146"	"Long-term depression"	24	-1.3992	0.92654	1	1.3992	0.073461	0.20746	-5.7235	0.19389	0.70498	9	-3.6919	0.36552	0.8629	15	-4.3799	0.1739	0.85095
"147"	"Long-term potentiation"	29	-5.7152	0.99999	1	5.7152	1.4227e-05	0.00072322	-2.2709	0.032442	0.30261	7	-5.5379	0.55942	0.93693	22	0.51653	0.0057374	0.24695
"148"	"Longevity regulating pathway"	44	0.41869	0.70208	1	-0.41869	0.29792	0.5048	-20.215	0.95336	0.99996	21	-10.347	0.68296	0.96722	23	-18.074	0.97379	0.99999
"149"	"Lysine degradation"	22	6.3338	0.00044333	0.0067607	-6.3338	0.99956	1	0.5627	0.011481	0.13468	16	3.5754	0.0084988	0.1202	6	-4.7612	0.46485	0.99999
"150"	"Lysosome"	41	2.8922	0.13139	0.91076	-2.8922	0.86861	1	-18.624	0.92416	0.99996	26	-11.1	0.67336	0.96722	15	-16.178	0.97644	0.99999
"151"	"MAPK signaling pathway"	80	-5.8133	1	1	5.8133	5.2963e-07	4.0385e-05	-20.039	0.71721	0.99996	26	-16.339	0.94547	0.99293	54	-13.053	0.27306	0.90413
"152"	"Malaria"	13	1.1892	0.33709	1	-1.1892	0.66291	0.84449	-9.4445	0.71697	0.99996	9	-5.6134	0.53211	0.93693	4	-8.6062	0.84413	0.99999
"153"	"Mannose type O-glycan biosynthesis"	1	0	0.56009	1	0	0.43991	0.66095	-8.2095	0.9261	0.99996	0				1	-8.2095	0.92345	0.99999
"154"	"Maturity onset diabetes of the young"	1	0	0.56009	1	0	0.43991	0.66095	-8.2095	0.9261	0.99996	1	-8.2095	0.93377	0.99293	0			
"155"	"Measles"	40	-1.2174	0.9329	1	1.2174	0.067099	0.19307	-19.888	0.95373	0.99996	12	-6.2891	0.49161	0.9241	28	-19.654	0.97738	0.99999
"156"	"Melanogenesis"	23	-2.1648	0.97356	1	2.1648	0.026442	0.1034	-7.5816	0.36655	0.95554	6	-2.0802	0.29814	0.8629	17	-7.5827	0.40259	0.99999
"157"	"Melanoma"	14	-1.1867	0.88274	1	1.1867	0.11726	0.2731	-12.822	0.91106	0.99996	4	-8.4731	0.87292	0.99293	10	-9.8128	0.77157	0.99999
"158"	"Metabolism of xenobiotics by cytochrome P450"	19	2.5715	0.11421	0.82938	-2.5715	0.88579	1	-4.1394	0.16847	0.69032	8	1.34	0.077878	0.60867	11	-6.583	0.45602	0.99999
"159"	"MicroRNAs in cancer"	43	-0.7543	0.89791	1	0.7543	0.10209	0.25125	-23.856	0.99576	0.99996	18	-14.791	0.93877	0.99293	25	-18.737	0.97517	0.99999
"160"	"Mineral absorption"	12	0.4592	0.52059	1	-0.4592	0.47941	0.69962	-4.6158	0.30647	0.86314	7	-3.2197	0.36108	0.8629	5	-3.3412	0.38899	0.99999
"161"	"Mismatch repair"	7	-0.53681	0.74272	1	0.53681	0.25728	0.45889	-7.1586	0.67137	0.99996	2	-3.8772	0.60246	0.95161	5	-6.018	0.64768	0.99999
"162"	"Mitophagy"	33	1.5576	0.36772	1	-1.5576	0.63228	0.82412	-15.149	0.8196	0.99996	16	-4.0965	0.23489	0.82447	17	-17.132	0.98275	0.99999
"163"	"Morphine addiction"	14	0.81481	0.45923	1	-0.81481	0.54077	0.73962	-6.9606	0.47923	0.99996	6	1.8081	0.085583	0.61996	8	-10.774	0.86915	0.99999
"164"	"Mucin type O-glycan biosynthesis"	1	1.8122	0.15723	0.99907	-1.8122	0.84277	0.9963	1.4761	0.2089	0.72643	1	1.4761	0.25376	0.8468	0			
"165"	"N-Glycan biosynthesis"	13	-0.53331	0.76062	1	0.53331	0.23938	0.4324	-10.063	0.76329	0.99996	6	-6.288	0.64722	0.95161	7	-7.8917	0.71847	0.99999
"166"	"NF-kappa B signaling pathway"	20	-0.0097952	0.69171	1	0.0097952	0.30829	0.51664	-20.713	0.9972	0.99996	7	-7.3697	0.70836	0.96722	13	-20.283	0.99881	0.99999
"167"	"NOD-like receptor signaling pathway"	50	1.2081	0.48872	1	-1.2081	0.51128	0.72195	-18.794	0.88529	0.99996	22	-3.4607	0.13294	0.75461	28	-22.046	0.99497	0.99999
"168"	"Natural killer cell mediated cytotoxicity"	27	-3.9155	0.99911	1	3.9155	0.00089408	0.010145	-9.3764	0.42802	0.98758	9	-11.063	0.90044	0.99293	18	-3.661	0.097557	0.76298
"169"	"Necroptosis"	58	0.48847	0.71094	1	-0.48847	0.28906	0.4953	-14.553	0.45662	0.98832	24	-4.3563	0.16409	0.75461	34	-15.347	0.77401	0.99999
"170"	"Neomycin, kanamycin and gentamicin biosynthesis"	2	1.6565	0.1985	1	-1.6565	0.8015	0.96624	0.98874	0.19259	0.70498	2	0.98874	0.20512	0.79117	0			
"171"	"Neuroactive ligand-receptor interaction"	9	0.37479	0.546	1	-0.37479	0.454	0.67219	-8.0504	0.68735	0.99996	7	-5.4048	0.54796	0.93693	2	-6.9659	0.83817	0.99999
"172"	"Neurotrophin signaling pathway"	48	-4.8039	0.99993	1	4.8039	6.5285e-05	0.0024593	-16.33	0.75152	0.99996	10	-5.8177	0.5159	0.93693	38	-15.369	0.70724	0.99999
"173"	"Nicotinate and nicotinamide metabolism"	18	1.4408	0.34883	1	-1.4408	0.65117	0.84009	-12.015	0.7897	0.99996	10	-4.9216	0.43611	0.86395	8	-12.521	0.93801	0.99999
"174"	"Nitrogen metabolism"	7	0.59697	0.46567	1	-0.59697	0.53433	0.7384	1.0429	0.08301	0.45211	4	0.85903	0.16178	0.75461	3	0.60108	0.15661	0.85095
"175"	"Non-alcoholic fatty liver disease (NAFLD)"	96	24.721	0	0	-24.721	1	1	10.798	8.0451e-12	4.0896e-10	79	21.21	0	0	17	-20.062	0.99774	0.99999
"176"	"Non-homologous end-joining"	5	-1.2783	0.85842	1	1.2783	0.14158	0.31043	-4.0141	0.46812	0.99844	1	-1.5792	0.50835	0.93693	4	-3.6982	0.44674	0.99999
"177"	"Non-small cell lung cancer"	23	-1.6754	0.94684	1	1.6754	0.053159	0.16889	-13.118	0.82902	0.99996	7	-9.2233	0.82957	0.9803	16	-9.6277	0.59207	0.99999
"178"	"Notch signaling pathway"	6	-0.25037	0.66344	1	0.25037	0.33656	0.55189	-16.798	0.99764	0.99996	2	-11.61	0.97621	0.99293	4	-12.364	0.97053	0.99999
"179"	"Nucleotide excision repair"	11	-2.4608	0.97701	1	2.4608	0.02299	0.093491	-8.1665	0.65505	0.99996	3	-5.4938	0.71073	0.96722	8	-6.2118	0.51443	0.99999
"180"	"Olfactory transduction"	11	-3.7805	0.99801	1	3.7805	0.0019937	0.019616	-6.9221	0.54308	0.99996	0				11	-6.9221	0.48756	0.99999
"181"	"One carbon pool by folate"	11	0.57347	0.48569	1	-0.57347	0.51431	0.72288	-6.4874	0.50264	0.99996	6	-5.4777	0.58046	0.93693	5	-3.6219	0.4158	0.99999
"182"	"Oocyte meiosis"	41	-7.4651	1	1	7.4651	5.1561e-08	5.242e-06	-4.3387	0.029221	0.2875	8	-8.9757	0.77686	0.96722	33	-0.41676	0.0017896	0.10666
"183"	"Osteoclast differentiation"	32	-4.4039	0.99961	1	4.4039	0.00038966	0.0056594	-18.128	0.94298	0.99996	9	-13.571	0.96696	0.99293	23	-12.894	0.75764	0.99999
"184"	"Other glycan degradation"	6	0.83755	0.39827	1	-0.83755	0.60173	0.79449	-4.4848	0.47872	0.99996	4	-6.2527	0.737	0.96722	2	1.0748	0.16696	0.85095
"185"	"Other types of O-glycan biosynthesis"	4	0.96156	0.34721	1	-0.96156	0.65279	0.84009	-4.1399	0.52852	0.99996	1	2.1516	0.20786	0.79149	3	-6.0226	0.6985	0.99999
"186"	"Ovarian steroidogenesis"	9	-0.55797	0.76048	1	0.55797	0.23952	0.4324	-9.8787	0.81604	0.99996	3	-8.2646	0.87825	0.99293	6	-6.2549	0.60777	0.99999
"187"	"Oxidative phosphorylation"	93	30.826	0	0	-30.826	1	1	26.914	0	0	87	27.297	0	0	6	2.0148	0.041898	0.60762
"188"	"Oxytocin signaling pathway"	63	-6.144	1	1	6.144	1.2871e-06	7.8512e-05	-8.7233	0.051091	0.36239	23	-10.117	0.63244	0.95161	40	-3.2764	0.0058009	0.24695
"189"	"PI3K-Akt signaling pathway"	101	-2.0617	0.995	1	2.0617	0.0049965	0.036499	-28.337	0.97362	0.99996	41	-17.925	0.93434	0.99293	60	-21.947	0.8977	0.99999
"190"	"PPAR signaling pathway"	35	5.9796	0.00054534	0.0072317	-5.9796	0.99945	1	-4.1499	0.044095	0.33938	26	-3.0635	0.09351	0.6439	9	-2.9768	0.20025	0.87028
"191"	"Pancreatic cancer"	31	-0.69202	0.86519	1	0.69202	0.13481	0.30233	-18.151	0.95304	0.99996	11	-7.5364	0.64245	0.95161	20	-17.009	0.96589	0.99999
"192"	"Pancreatic secretion"	23	-0.027159	0.70343	1	0.027159	0.29657	0.5048	-9.2851	0.52245	0.99996	12	-6.4521	0.50619	0.93693	11	-6.6873	0.46569	0.99999
"193"	"Pantothenate and CoA biosynthesis"	8	0.29936	0.54648	1	-0.29936	0.45352	0.67219	-7.3621	0.68163	0.99996	5	-6.8197	0.74003	0.96722	3	-3.218	0.44941	0.99999
"194"	"Parathyroid hormone synthesis, secretion and action"	23	-0.61972	0.82195	1	0.61972	0.17805	0.36017	-13.328	0.84117	0.99996	7	-8.0893	0.75971	0.96722	16	-10.629	0.68088	0.99999
"195"	"Parkinson disease"	98	30.888	0	0	-30.888	1	1	25.377	0	0	89	27.884	0	0	9	-3.9467	0.27029	0.90413
"196"	"Pathogenic Escherichia coli infection"	33	0.64218	0.59088	1	-0.64218	0.40912	0.62973	-10.412	0.42265	0.98758	20	-7.5263	0.43235	0.86395	13	-7.2545	0.47426	0.99999
"197"	"Pathways in cancer"	140	-1.1704	0.98453	1	1.1704	0.015472	0.076114	-30.091	0.94913	0.99996	55	-11.835	0.39898	0.86395	85	-29.098	0.99069	0.99999
"198"	"Pentose and glucuronate interconversions"	7	2.0566	0.15007	0.99345	-2.0566	0.84993	0.99703	2.109	0.052313	0.36262	4	2.8621	0.074397	0.59719	3	-0.083338	0.19751	0.87028
"199"	"Pentose phosphate pathway"	22	-4.0164	0.99858	1	4.0164	0.0014197	0.014433	-4.8251	0.15908	0.6834	7	-5.699	0.57322	0.93693	15	-1.9503	0.061655	0.61798
"200"	"Peroxisome"	42	8.161	2.1454e-06	4.0897e-05	-8.161	1	1	-8.7852	0.18271	0.69657	34	-5.7862	0.15477	0.75461	8	-8.2008	0.69489	0.99999
"201"	"Pertussis"	28	-1.2495	0.9035	1	1.2495	0.096495	0.24323	-11.222	0.58286	0.99996	12	-4.6307	0.34717	0.8629	16	-10.835	0.69807	0.99999
"202"	"Phagosome"	59	-0.11003	0.81284	1	0.11003	0.18716	0.37309	-12.92	0.30847	0.86314	34	-13.145	0.72215	0.96722	25	-4.5194	0.069361	0.66676
"203"	"Phenylalanine metabolism"	6	3.7172	0.019847	0.20178	-3.7172	0.98015	1	-0.452	0.15962	0.6834	3	5.1741	0.036249	0.35887	3	-5.8134	0.68146	0.99999
"204"	"Phenylalanine, tyrosine and tryptophan biosynthesis"	2	5.3956	0.00053719	0.0072317	-5.3956	0.99946	1	5.1484	0.03639	0.31939	2	5.1484	0.040106	0.37223	0			
"205"	"Phosphatidylinositol signaling system"	28	-1.9369	0.95835	1	1.9369	0.041646	0.1477	-17.167	0.93841	0.99996	11	-20.218	0.99949	0.99949	17	-5.7684	0.24346	0.87028
"206"	"Phospholipase D signaling pathway"	40	-1.2485	0.93546	1	1.2485	0.064544	0.18929	-12.789	0.53104	0.99996	17	-10.996	0.77704	0.96722	23	-7.4123	0.26952	0.90413
"207"	"Phosphonate and phosphinate metabolism"	2	1.5383	0.22054	1	-1.5383	0.77946	0.9434	2.2923	0.12333	0.55315	1	2.8807	0.16428	0.75461	1	0.36106	0.27105	0.90413
"208"	"Phototransduction"	2	-0.96586	0.80304	1	0.96586	0.19696	0.38508	-5.1358	0.68961	0.99996	0				2	-5.1358	0.70623	0.99999
"209"	"Platelet activation"	53	-1.1723	0.93755	1	1.1723	0.062455	0.18817	-15.466	0.59931	0.99996	26	-12.6	0.78214	0.96722	27	-9.3042	0.31671	0.94194
"210"	"Porphyrin and chlorophyll metabolism"	18	6.1544	0.00054513	0.0072317	-6.1544	0.99945	1	0.4999	0.020856	0.23559	14	3.5459	0.011436	0.14768	4	-5.5733	0.61933	0.99999
"211"	"Primary bile acid biosynthesis"	6	2.9895	0.054547	0.44965	-2.9895	0.94545	1	-1.4156	0.22042	0.74363	6	-1.4156	0.25043	0.8468	0			
"212"	"Primary immunodeficiency"	3	0.62398	0.40481	1	-0.62398	0.59519	0.79271	-9.1427	0.89622	0.99996	2	-5.3925	0.72475	0.96722	1	-8.2095	0.92345	0.99999
"213"	"Prion diseases"	21	-1.5361	0.93121	1	1.5361	0.068787	0.19608	-14.027	0.88612	0.99996	8	-9.9195	0.83177	0.9803	13	-10.046	0.72584	0.99999
"214"	"Progesterone-mediated oocyte maturation"	25	-2.5636	0.9875	1	2.5636	0.012499	0.065403	-12.409	0.73212	0.99996	7	-6.1346	0.61007	0.95161	18	-10.798	0.65955	0.99999
"215"	"Prolactin signaling pathway"	24	-3.1209	0.99487	1	3.1209	0.0051308	0.036499	-12.41	0.75736	0.99996	4	-5.9337	0.71274	0.96722	20	-10.941	0.6341	0.99999
"216"	"Propanoate metabolism"	29	13.824	5.5511e-16	1.6931e-14	-13.824	1	1	8.2738	1.2211e-05	0.00033858	24	11.865	2.071e-06	5.5917e-05	5	-6.0698	0.65241	0.99999
"217"	"Prostate cancer"	30	-0.96389	0.89703	1	0.96389	0.10297	0.25125	-18.823	0.96126	0.99996	8	-3.3242	0.3324	0.8629	22	-19.976	0.99197	0.99999
"218"	"Proteasome"	39	-9.3276	1	1	9.3276	2.8534e-12	8.7028e-10	5.3516	5.3259e-05	0.0011603	5	-3.3783	0.45093	0.86404	34	7.0271	1.0961e-06	0.00032664
"219"	"Protein digestion and absorption"	26	-1.3863	0.92517	1	1.3863	0.074827	0.20762	-9.9055	0.48391	0.99996	10	-6.4597	0.57284	0.93693	16	-7.5203	0.39503	0.99999
"220"	"Protein export"	14	1.3147	0.33548	1	-1.3147	0.66452	0.84449	-4.0323	0.22628	0.74363	8	-4.4035	0.41874	0.86395	6	-1.0748	0.16332	0.85095
"221"	"Protein processing in endoplasmic reticulum"	97	-2.4032	0.9943	1	2.4032	0.0056951	0.039477	-16.149	0.23801	0.76413	43	-13.239	0.62736	0.95161	54	-9.8305	0.088419	0.76298
"222"	"Proteoglycans in cancer"	83	-2.1744	0.99261	1	2.1744	0.0073883	0.046946	-16.535	0.381	0.96037	37	-14.126	0.75629	0.96722	46	-9.5419	0.13104	0.83087
"223"	"Proximal tubule bicarbonate reclamation"	10	2.481	0.12122	0.8598	-2.481	0.87878	1	-0.28928	0.096534	0.49903	7	-0.41107	0.16664	0.75461	3	0.099774	0.18598	0.85265
"224"	"Purine metabolism"	56	-0.54235	0.89056	1	0.54235	0.10944	0.26491	-8.9011	0.092687	0.4874	32	-7.6373	0.29109	0.8629	24	-4.778	0.10497	0.76298
"225"	"Pyrimidine metabolism"	28	0.53175	0.57428	1	-0.53175	0.42572	0.64856	-16.973	0.93296	0.99996	14	-7.903	0.6248	0.95161	14	-16.101	0.97603	0.99999
"226"	"Pyruvate metabolism"	34	7.1627	3.6332e-05	0.00061562	-7.1627	0.99996	1	4.5291	0.00010576	0.0021504	22	6.3082	0.00042264	0.0096557	12	-0.91766	0.054683	0.61798
"227"	"RIG-I-like receptor signaling pathway"	21	-0.20245	0.73713	1	0.20245	0.26287	0.46613	-17.652	0.9787	0.99996	6	-2.153	0.3036	0.8629	15	-19.525	0.99756	0.99999
"228"	"RNA degradation"	36	-0.53131	0.84483	1	0.53131	0.15517	0.32865	-16.455	0.85976	0.99996	11	-5.029	0.4161	0.86395	25	-16.41	0.91914	0.99999
"229"	"RNA polymerase"	9	-0.35096	0.71783	1	0.35096	0.28217	0.48702	-21.71	0.99982	0.99996	2	-11.61	0.97621	0.99293	7	-18.411	0.99918	0.99999
"230"	"RNA transport"	92	-7.3519	1	1	7.3519	6.48e-10	9.8821e-08	-16.74	0.34237	0.90802	17	-15.159	0.957	0.99293	75	-11.323	0.048328	0.60762
"231"	"Rap1 signaling pathway"	52	0.025306	0.78162	1	-0.025306	0.21838	0.41371	-13.809	0.45709	0.98832	24	-6.8265	0.33521	0.8629	28	-12.499	0.61549	0.99999
"232"	"Ras signaling pathway"	59	-0.39554	0.85732	1	0.39554	0.14268	0.31043	-24.954	0.99105	0.99996	21	-8.4246	0.52236	0.93693	38	-24.832	0.99737	0.99999
"233"	"Regulation of actin cytoskeleton"	97	-0.79613	0.93553	1	0.79613	0.064467	0.18929	-16.796	0.28696	0.82721	50	-12.464	0.44769	0.86395	47	-11.274	0.23394	0.87028
"234"	"Regulation of lipolysis in adipocytes"	16	1.6287	0.26918	1	-1.6287	0.73082	0.90942	-12.133	0.85532	0.99996	7	-0.38412	0.16518	0.75461	9	-15.839	0.98586	0.99999
"235"	"Relaxin signaling pathway"	41	-1.9538	0.97087	1	1.9538	0.029126	0.11232	-14.241	0.66024	0.99996	11	-1.7202	0.16524	0.75461	30	-15.607	0.8359	0.99999
"236"	"Renal cell carcinoma"	30	-1.6394	0.95526	1	1.6394	0.044738	0.15506	-7.0227	0.17654	0.69032	11	-4.4623	0.36608	0.8629	19	-5.4291	0.18561	0.85265
"237"	"Renin secretion"	19	-3.0272	0.99298	1	3.0272	0.0070157	0.045528	-2.8224	0.10342	0.50878	8	-4.4579	0.42324	0.86395	11	0.092402	0.047347	0.60762
"238"	"Renin-angiotensin system"	11	-0.53705	0.76041	1	0.53705	0.23959	0.4324	-2.2564	0.16301	0.6834	6	-3.7911	0.43615	0.86395	5	0.80623	0.095757	0.76298
"239"	"Retinol metabolism"	9	1.5386	0.2665	1	-1.5386	0.7335	0.90942	-5.4208	0.4585	0.98832	5	-2.5443	0.37861	0.86395	4	-5.2866	0.59359	0.99999
"240"	"Retrograde endocannabinoid signaling"	61	18.378	0	0	-18.378	1	1	13.565	5.5331e-11	2.4109e-09	47	18.431	3.8471e-12	1.6323e-10	14	-5.4539	0.27214	0.90413
"241"	"Rheumatoid arthritis"	16	-1.0592	0.86963	1	1.0592	0.13037	0.29453	-10.095	0.71931	0.99996	7	-9.734	0.85627	0.99293	9	-4.876	0.34726	0.96714
"242"	"Riboflavin metabolism"	5	-0.0097676	0.60794	1	0.0097676	0.39206	0.61056	-4.7223	0.53424	0.99996	2	-5.6877	0.74625	0.96722	3	-1.4525	0.29647	0.92219
"243"	"Ribosome"	111	1.348	0.60787	1	-1.348	0.39213	0.61056	-3.0665	1.7923e-05	0.00045553	41	-1.1826	0.010907	0.14725	70	-2.9565	0.00031132	0.046387
"244"	"Ribosome biogenesis in eukaryotes"	22	-1.1149	0.88801	1	1.1149	0.11199	0.26894	-14.659	0.90831	0.99996	11	-12.8	0.9425	0.99293	11	-7.9309	0.58108	0.99999
"245"	"SNARE interactions in vesicular transport"	18	-0.44558	0.77733	1	0.44558	0.22267	0.41655	-14.316	0.90786	0.99996	12	-14.124	0.95873	0.99293	6	-4.8216	0.47067	0.99999
"246"	"Salivary secretion"	22	0.14069	0.6739	1	-0.14069	0.3261	0.53762	-9.734	0.56521	0.99996	10	-4.2799	0.38036	0.86395	12	-9.2729	0.69331	0.99999
"247"	"Salmonella infection"	45	-0.84533	0.90834	1	0.84533	0.091665	0.23494	-11.973	0.38743	0.96857	23	-8.7188	0.50689	0.93693	22	-8.2097	0.335	0.96714
"248"	"Selenocompound metabolism"	9	1.7607	0.22229	1	-1.7607	0.77771	0.9434	1.6186	0.045462	0.33938	6	1.9041	0.082391	0.61176	3	0.11064	0.18531	0.85265
"249"	"Serotonergic synapse"	26	-0.44006	0.80011	1	0.44006	0.19989	0.38833	-9.2797	0.42757	0.98758	11	-5.6036	0.46825	0.88846	15	-7.4186	0.42633	0.99999
"250"	"Shigellosis"	39	-0.035578	0.78835	1	0.035578	0.21165	0.40346	-13.211	0.59056	0.99996	20	-5.6779	0.28028	0.8629	19	-13.101	0.83028	0.99999
"251"	"Signaling pathways regulating pluripotency of stem cells"	19	-2.8284	0.99	1	2.8284	0.0099956	0.057923	-9.0496	0.56589	0.99996	4	-4.0728	0.55455	0.93693	15	-8.0818	0.49148	0.99999
"252"	"Small cell lung cancer"	34	-0.45997	0.84842	1	0.45997	0.15158	0.32329	-22.492	0.99585	0.99996	11	-4.7779	0.39371	0.86395	23	-24.043	0.99962	0.99999
"253"	"Sphingolipid metabolism"	7	-0.015388	0.62263	1	0.015388	0.37737	0.59947	-13.978	0.97526	0.99996	6	-15.937	0.99304	0.99949	1	2.0547	0.15566	0.85095
"254"	"Sphingolipid signaling pathway"	45	-1.3487	0.9513	1	1.3487	0.048698	0.16026	-17.261	0.82146	0.99996	19	-11.642	0.81069	0.97645	26	-12.757	0.70553	0.99999
"255"	"Spliceosome"	94	-3.129	0.99923	1	3.129	0.00077345	0.0098293	-31.424	0.99785	0.99996	22	-16.983	0.97541	0.99293	72	-26.518	0.98246	0.99999
"256"	"Staphylococcus aureus infection"	15	0.20392	0.6293	1	-0.20392	0.3707	0.59196	-11.332	0.81973	0.99996	9	-5.6131	0.53209	0.93693	6	-11.043	0.92407	0.99999
"257"	"Starch and sucrose metabolism"	19	-2.2979	0.97613	1	2.2979	0.023872	0.095803	-2.2424	0.081465	0.45176	9	-4.6092	0.44387	0.86395	10	1.2817	0.026468	0.60672
"258"	"Steroid biosynthesis"	6	0.9615	0.36872	1	-0.9615	0.63128	0.82412	-8.1518	0.78924	0.99996	5	-9.5062	0.89288	0.99293	1	1.2887	0.20319	0.87028
"259"	"Steroid hormone biosynthesis"	6	0.731	0.42417	1	-0.731	0.57583	0.7737	-1.8817	0.25404	0.78688	3	1.1309	0.1828	0.76468	3	-3.792	0.50212	0.99999
"260"	"Sulfur metabolism"	6	4.113	0.010607	0.11156	-4.113	0.98939	1	3.575	0.026354	0.2737	5	3.9581	0.039384	0.37223	1	-0.09368	0.30801	0.94194
"261"	"Sulfur relay system"	6	2.5286	0.094372	0.71602	-2.5286	0.90563	1	-1.2923	0.21198	0.72643	4	2.4605	0.088147	0.62333	2	-5.718	0.75296	0.99999
"262"	"Synaptic vesicle cycle"	24	-0.55839	0.81734	1	0.55839	0.18266	0.36652	-7.6688	0.34112	0.90802	15	-10.842	0.80563	0.97645	9	1.4738	0.029339	0.60762
"263"	"Synthesis and degradation of ketone bodies"	8	5.3221	0.00098749	0.012549	-5.3221	0.99901	1	-1.1594	0.16357	0.6834	7	1.8635	0.07172	0.59169	1	-8.2095	0.92345	0.99999
"264"	"Systemic lupus erythematosus"	22	-1.3068	0.90873	1	1.3068	0.091265	0.23494	-11.708	0.73616	0.99996	12	-9.7427	0.77443	0.96722	10	-6.6927	0.4962	0.99999
"265"	"T cell receptor signaling pathway"	36	-4.6371	0.99989	1	4.6371	0.00010504	0.0029126	-13.726	0.67875	0.99996	8	-9.8431	0.82767	0.9803	28	-10.303	0.40877	0.99999
"266"	"TGF-beta signaling pathway"	15	-2.4614	0.9835	1	2.4614	0.016503	0.078648	-9.5383	0.68923	0.99996	5	-11.621	0.95666	0.99293	10	-3.4645	0.21501	0.87028
"267"	"TNF signaling pathway"	26	-1.7456	0.95235	1	1.7456	0.047648	0.1597	-19.081	0.97958	0.99996	6	-5.3122	0.56645	0.93693	20	-18.847	0.98846	0.99999
"268"	"Taste transduction"	2	-0.80037	0.77195	1	0.80037	0.22805	0.41901	-5.345	0.70585	0.99996	0				2	-5.345	0.72349	0.99999
"269"	"Taurine and hypotaurine metabolism"	2	0.94971	0.34866	1	-0.94971	0.65134	0.84009	-5.1557	0.69117	0.99996	1	0.91826	0.29533	0.8629	1	-8.2095	0.92345	0.99999
"270"	"Terpenoid backbone biosynthesis"	15	0.85339	0.45656	1	-0.85339	0.54344	0.73995	-9.5969	0.69406	0.99996	8	-4.7551	0.44798	0.86395	7	-8.9651	0.79967	0.99999
"271"	"Th1 and Th2 cell differentiation"	22	-4.9852	0.99982	1	4.9852	0.00017504	0.0038848	-9.5692	0.54981	0.99996	3	-11.287	0.96656	0.99293	19	-5.812	0.21131	0.87028
"272"	"Th17 cell differentiation"	28	-4.769	0.99977	1	4.769	0.00022929	0.0042963	-9.3342	0.41531	0.98758	6	-11.025	0.91917	0.99293	22	-4.773	0.10494	0.76298
"273"	"Thermogenesis"	132	27.931	0	0	-27.931	1	1	14.165	0	0	112	19.372	0	0	20	-9.4516	0.4917	0.99999
"274"	"Thiamine metabolism"	7	1.7911	0.19397	1	-1.7911	0.80603	0.96787	-1.1706	0.18632	0.70157	5	-1.49	0.29321	0.8629	2	0.16602	0.22799	0.87028
"275"	"Thyroid cancer"	11	-1.3748	0.89769	1	1.3748	0.10231	0.25125	-4.4102	0.31603	0.87627	3	-4.4368	0.62648	0.95161	8	-2.4544	0.19533	0.87028
"276"	"Thyroid hormone signaling pathway"	42	-1.0498	0.91164	1	1.0498	0.088359	0.23034	-14.217	0.63567	0.99996	15	-5.0012	0.32785	0.8629	27	-14.004	0.74553	0.99999
"277"	"Thyroid hormone synthesis"	21	1.5023	0.32547	1	-1.5023	0.67453	0.85366	-4.6022	0.17625	0.69032	13	-1.2968	0.13596	0.75461	8	-5.8033	0.47565	0.99999
"278"	"Tight junction"	80	-1.4891	0.97951	1	1.4891	0.020494	0.090556	-21.297	0.8071	0.99996	43	-15.209	0.77999	0.96722	37	-14.921	0.70618	0.99999
"279"	"Toll-like receptor signaling pathway"	29	-1.8739	0.96312	1	1.8739	0.036884	0.13392	-18.412	0.96311	0.99996	7	-5.5401	0.5596	0.93693	22	-18.015	0.97353	0.99999
"280"	"Toxoplasmosis"	41	-1.1614	0.91939	1	1.1614	0.08061	0.21758	-12.349	0.48909	0.99996	13	-0.75869	0.11272	0.69748	28	-14.427	0.7746	0.99999
"281"	"Transcriptional misregulation in cancer"	23	1.2635	0.37755	1	-1.2635	0.62245	0.81831	-26.03	0.99996	0.99996	14	-13.616	0.94657	0.99293	9	-24.629	0.99999	0.99999
"282"	"Tryptophan metabolism"	21	7.3219	1.5692e-05	0.00028153	-7.3219	0.99998	1	1.3751	0.011174	0.13468	18	3.0792	0.0083583	0.1202	3	-3.9043	0.51246	0.99999
"283"	"Tuberculosis"	54	-1.855	0.97922	1	1.855	0.020783	0.090556	-14.712	0.51941	0.99996	18	-7.0301	0.43431	0.86395	36	-13.048	0.53567	0.99999
"284"	"Type I diabetes mellitus"	5	1.3125	0.28802	1	-1.3125	0.71198	0.88997	-5.9203	0.64303	0.99996	2	-3.0944	0.53405	0.93693	3	-5.1164	0.62208	0.99999
"285"	"Type II diabetes mellitus"	18	0.018511	0.68434	1	-0.018511	0.31566	0.52325	-10.149	0.6486	0.99996	6	-0.25446	0.17785	0.75461	12	-12.25	0.89539	0.99999
"286"	"Tyrosine metabolism"	13	3.0699	0.049183	0.41669	-3.0699	0.95082	1	-0.28712	0.061128	0.38502	6	4.3918	0.027067	0.27721	7	-4.4573	0.39728	0.99999
"287"	"Ubiquinone and other terpenoid-quinone biosynthesis"	6	5.151	0.0015753	0.017795	-5.151	0.99842	1	-1.897	0.25519	0.78688	4	5.8861	0.016454	0.18795	2	-11.61	0.98279	0.99999
"288"	"Ubiquitin mediated proteolysis"	51	-4.5374	0.99993	1	4.5374	7.2571e-05	0.0024593	-18.927	0.8624	0.99996	9	-11.026	0.899	0.99293	42	-15.752	0.67861	0.99999
"289"	"VEGF signaling pathway"	28	-4.075	0.99893	1	4.075	0.0010715	0.01127	-9.4847	0.42851	0.98758	10	-11.114	0.8899	0.99293	18	-3.5455	0.092878	0.76298
"290"	"Valine, leucine and isoleucine degradation"	41	17.231	0	0	-17.231	1	1	11.668	9.6004e-09	3.6602e-07	38	14.322	6.1763e-09	2.293e-07	3	-7.8376	0.82612	0.99999
"291"	"Vascular smooth muscle contraction"	40	-1.9504	0.97542	1	1.9504	0.024576	0.097346	-9.189	0.23094	0.74932	17	-8.1447	0.54313	0.93693	23	-5.1159	0.12214	0.80884
"292"	"Vasopressin-regulated water reabsorption"	22	-2.6374	0.98399	1	2.6374	0.016014	0.07753	-3.057	0.078251	0.44198	6	-2.76	0.35081	0.8629	16	-1.8945	0.054947	0.61798
"293"	"Vibrio cholerae infection"	21	-0.75092	0.8375	1	0.75092	0.1625	0.33488	-6.16	0.28206	0.82721	11	-7.3246	0.62411	0.95161	10	-1.2446	0.092532	0.76298
"294"	"Viral carcinogenesis"	66	-3.3609	0.9991	1	3.3609	0.00089804	0.010145	-17.883	0.67476	0.99996	21	-14.432	0.91444	0.99293	45	-11.798	0.28506	0.91361
"295"	"Viral myocarditis"	25	-4.0316	0.99927	1	4.0316	0.00072743	0.0096464	-2.1918	0.039287	0.32385	7	-3.7583	0.40585	0.86395	18	-0.23929	0.017263	0.46766
"296"	"Vitamin B6 metabolism"	3	0.39351	0.46254	1	-0.39351	0.53746	0.7384	-0.56555	0.26149	0.79755	2	-0.3535	0.2999	0.8629	1	-0.47963	0.34101	0.96714
"297"	"Vitamin digestion and absorption"	5	0.65995	0.44117	1	-0.65995	0.55883	0.75417	-5.2086	0.5792	0.99996	4	-1.7186	0.34475	0.8629	1	-8.2095	0.92345	0.99999
"298"	"Wnt signaling pathway"	37	-4.6827	0.99971	1	4.6827	0.00028542	0.0043526	-11.972	0.50792	0.99996	8	-9.1566	0.78811	0.96722	29	-8.7131	0.2705	0.90413
"299"	"alpha-Linolenic acid metabolism"	4	1.5171	0.22486	1	-1.5171	0.77514	0.9434	-7.5533	0.8027	0.99996	3	-7.8085	0.85673	0.99293	1	-1.5818	0.44134	0.99999
"300"	"beta-Alanine metabolism"	18	5.7083	0.0013776	0.016161	-5.7083	0.99862	1	-0.35641	0.032741	0.30261	12	4.6251	0.0067775	0.10594	6	-7.1582	0.68873	0.99999
"301"	"cAMP signaling pathway"	56	-2.649	0.99524	1	2.649	0.0047642	0.036499	-13.56	0.39846	0.98758	24	-11.532	0.73442	0.96722	32	-7.9513	0.17534	0.85095
"302"	"cGMP-PKG signaling pathway"	56	-0.47342	0.88197	1	0.47342	0.11803	0.2731	-4.3671	0.0090659	0.12578	29	-2.2828	0.043686	0.38533	27	-3.9234	0.037596	0.60762
"303"	"mRNA surveillance pathway"	43	-2.6769	0.99403	1	2.6769	0.0059725	0.04048	-17.404	0.86561	0.99996	15	-10.468	0.78176	0.96722	28	-13.906	0.73561	0.99999
"304"	"mTOR signaling pathway"	59	-3.1717	0.99758	1	3.1717	0.0024172	0.021684	-17.341	0.70997	0.99996	19	-10.522	0.7345	0.96722	40	-13.809	0.54121	0.99999
"305"	"p53 signaling pathway"	11	0.86392	0.40891	1	-0.86392	0.59109	0.79071	-11.819	0.89483	0.99996	4	-2.8342	0.44228	0.86395	7	-12.674	0.95961	0.99999
